# SLC35G3

## Overview
SLC35G3 is a gene that encodes the protein solute carrier family 35 member G3, which is part of the solute carrier (SLC) family of proteins. These proteins are integral to the transport of various molecules across cellular membranes, contributing to essential cellular functions such as metabolism and homeostasis. The SLC35G3 protein is believed to facilitate the transport of specific substrates, potentially playing a role in processes like glycosylation or nucleotide metabolism within cellular compartments such as the endoplasmic reticulum or Golgi apparatus. In particular, SLC35G3 has been implicated in the maintenance of spermatogonial stem cells (SSCs) and is associated with metabolic processes like glycolysis and gluconeogenesis (Li2024Singlecell). Additionally, the gene has been identified in studies related to Alzheimer's disease and squamous cell carcinoma, suggesting its potential involvement in various pathological conditions (Gorlova2022Identification; Willett2024Identification). Despite these associations, the precise molecular functions and clinical implications of SLC35G3 remain to be fully elucidated.

## Function
SLC35G3 is a member of the solute carrier family, which is involved in the transport of various molecules across cellular membranes. These proteins typically facilitate the movement of nucleotides, sugars, and other small molecules, playing crucial roles in cellular metabolism and homeostasis. SLC35G3's specific function in healthy human cells may involve the transport of specific substrates, contributing to cellular processes such as glycosylation or nucleotide metabolism. Its activity is likely localized to specific cellular compartments, such as the endoplasmic reticulum or Golgi apparatus, where it supports essential biochemical pathways. 

In the context of spermatogonial stem cells (SSCs), SLC35G3 has been associated with the SSC state, suggesting its involvement in cell cycle and glycolysis/gluconeogenesis processes (Li2024Singlecell). This indicates that SLC35G3 may play a role in maintaining the metabolic requirements necessary for SSC regeneration and function. However, its precise molecular function in human biology remains to be fully elucidated. In cancer research, SLC35G3 has been identified as having a higher than expected number of mutations in squamous cell carcinoma, although its specific role in cancer biology is not well defined (Gorlova2022Identification).

## Clinical Significance
The SLC35G3 gene has been implicated in several diseases through its association with genetic variants and mutations. In Alzheimer's disease (AD), SLC35G3 was identified as one of the novel loci associated with the condition through a multi-ancestry meta-analysis of whole genome sequencing datasets. This study highlighted the gene's potential role in AD, particularly in diverse populations, suggesting that it could serve as a new pharmacological and biological target for treatment and prevention (Willett2024Identification).

In the context of lung cancer, SLC35G3 has been mentioned in studies focusing on squamous cell carcinoma. The gene was reported to have a higher than expected mutation rate, indicating its possible involvement in cancer development. However, the specific clinical significance of SLC35G3 in lung cancer remains unclear, as the study primarily aimed to identify genes with excess potentially functional mutations (Gorlova2022Identification).

Additionally, SLC35G3 has been associated with spermatogonial stem cell (SSC) regeneration following germ cell injury. In a mouse model, the gene was linked to the SSC state and cell cycle processes, suggesting a role in cellular regeneration and repair mechanisms (Li2024Singlecell).


## References


[1. (Gorlova2022Identification) Olga Y. Gorlova, Marek Kimmel, Spiridon Tsavachidis, Christopher I. Amos, and Ivan P. Gorlov. Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes. Oncotarget, 13(1):756–767, May 2022. URL: http://dx.doi.org/10.18632/oncotarget.28231, doi:10.18632/oncotarget.28231. This article has 3 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.28231)

2. (Willett2024Identification) Identification of 16 novel Alzheimer’s disease susceptibility loci using multi-ancestry meta-analyses of clinical Alzheimer’s disease and AD-by-proxy cases from four whole genome sequencing datasets. This article has 0 citations.

[3. (Li2024Singlecell) Shuang Li, Rong-Ge Yan, Xue Gao, Zhen He, Shi-Xin Wu, Yu-Jun Wang, Yi-Wen Zhang, Hai-Ping Tao, Xiao-Na Zhang, Gong-Xue Jia, and Qi-En Yang. Single-cell transcriptome analyses reveal critical regulators of spermatogonial stem cell fate transitions. BMC Genomics, February 2024. URL: http://dx.doi.org/10.1186/s12864-024-10072-0, doi:10.1186/s12864-024-10072-0. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12864-024-10072-0)